Your session is about to expire
← Back to Search
High-Dose Exercise for Concussion Recovery (MEDIC Trial)
MEDIC Trial Summary
This trial is testing if a high-dose exercise program can help reduce concussion symptoms, improve physiological function, and prevent long-term effects.
MEDIC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMEDIC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MEDIC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 13 and 18 years old.
- Group 1: High Dose Exercise
- Group 2: Standard-of-care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the High Dose Exercise regimen gained authorization from the Food and Drug Administration?
"High Dose Exercise was judged to have a safety rating of 2, due to the fact that Phase 2 trials have established some level of security without any evidence on efficacy."
Are there any opportunities for participation in this trial currently available?
"Data hosted on clinicaltrials.gov confirms that this particular medical trial is actively recruiting participants, having been initially posted in August of 2022 and last updated in October of the same year."
What are the eligibility criteria for participating in this research project?
"Aspiring participants must be from ages 13 to 18 and have a history of treatment. Altogether, 216 patients are required for full enrolment in this trial."
What is the fundamental purpose of this research effort?
"The primary aim of this medical investigation, which is to be assessed across Baseline and Visit 2 (35 days after the initial visit), will focus on measuring GFAP in serum biomarkers. Additional objectives include monitoring changes in VEGF levels through venipuncture at 3 separate visits, assessing kinesiophobia severity via the Tampa Scale of Kinesiophobia questionnaire, and evaluating interleukin-1 receptor antagonist concentrations using digital array technology."
How many participants has this experiment recruited thus far?
"Affirmative. Clinicaltrials.gov documents that this clinical trial is actively enrolling participants; it was initially posted on August 5th, 2022 and most recently edited on October 3rd, 2022. A total of 216 patients are being sought from three different locations."
Does this research accept those aged eighty-five and above as participants?
"As per the requirements of this medical trial, participants must be aged between 13 and 18."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger